Fusion and Cyteir refocus pipelines; Nona Biosciences collaborating with PharmaEssentia
Several biotechs are looking to make changes to their pipelines as the quarter has drawn to a close.
Massachusetts-based Cyteir said Wednesday it is going …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
